Education Interventions Model for Rational Drug Use (RDU)

Asthma Clinical Trial

Official title:

Education Interventions Model for Rational Drug Use

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01281215
• Other study ID #: FR - 381298
• Status: Completed
• Phase: N/A
• Start date: March 2011
• Est. completion date: October 2012

Study information

• Verified date: October 2018
• Source: University of Sao Paulo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to develop, implement and evaluate an economically viable and efficient interventions education model for rational drug use, adaptable to different pathological situations and should be implemented into Brazil Heath Care System.

Description:

Currently, the educational interventions regarding the use of medicines need to be expanded and more effective, and thus set themselves up in strategies for reorganization of dispensing drugs in health services and provide support to the population to obtain greater control over their health. The pharmacist, in turn, inserted in the multidisciplinary team has an important role in health education with the aim of improving knowledge about the disease and the various treatment options, reflecting positively on treatment adherence and clinical outcomes as a result and quality of life related to patient health. Thus, health education, to share knowledge, represents an important task and involves attentive listening to the community to identify their needs and then solve them. From this perspective, therefore, the educational means to educate health and an integral formation of individuals as social actors critics who understand and question the social relations, transforming subjects into citizens participating in the process of health education, helping to raise awareness , knowledge and understanding of living conditions and relationships with health, promoting quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: October 2012
• Est. primary completion date: October 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subject with asthma diagnosed according to criteria of the Global Strategy for Asthma Management and Prevention;

• Subject is a male or female with 18 to 73 years-old;

• Subject who has access to medications supplied by the the Brazil Heath Care System;

• Subject unable to perform the procedures or conditions such as pregnancy that may affect the results of the study;

• Literate subject without Cognitive Disorders, Alzheimer's, Dementia, that can limit the ability to participate in this study;

• Subject who have availability to attend the monthly meetings;

• Subject provides written informed consent and attend the first evaluation.

Exclusion Criteria:

• Subject who cannot be classified in the inclusion criteria.

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• Education interventional
The patients will receive pharmaceutical education to know more about asthma, the importance of treatment compliance, the medications used to control the pathology, corrected patients' inhalation techniques and the medication care.

Locations

Country	Name	City	State
Brazil	Clinical Hospital of Medicine Faculty of Ribeirão Preto, University of São Paolo	Ribeirão Preto	Sao Paolo

Sponsors (1)

Lead Sponsor	Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knowledge of Asthma	To compare the patient´s knowledge of asthma before and after the education interventions with asthma knowledge questionnaire.	6 months after the first evaluation
Secondary	Spirometry Exam	To compare the patient´s pulmonary function before and after the education interventions with spirometry exam.	6 months after the first evaluation
Secondary	Sociodemographic data, clinical and lifestyle evaluation	To evaluate the sociodemographic data, clinical and lifestyle before and after the education interventions and its impact on the quality of life.	6 months after the first evaluation
Secondary	Management of inhalers	To evaluate the technique for using inhalation devices among asthma patients before and after education interventions. Patients will be asked to demonstrate their inhaler technique.	6 months after the first evaluation
Secondary	Treatment compliance evaluation	To evaluate the treatment compliance with Morisky&Green test and pharmacy database query before and after educations interventions.	6 months after the first evaluation
Secondary	Economic analysis	Economic analysis after the model implementation.	6 months after the first evaluation
Secondary	Quality of Life Evaluation	To compare the Quality of Life before and after the education interventions	6 months after the first evaluation